Chromax

Chromax is an investigational oral nutraceutical combination of **garcinia extract** and **chromium picolinate** being studied by Benha University for symptomatic benign prostatic hyperplasia. The registered study evaluates its efficacy and safety against silodosin and placebo. Its proposed rationale in benign prostatic hyperplasia is the potential antioxidant activity of garcinia-derived constituents and chromium-related metabolic effects; however, a specific validated molecular target or disease-modifying mechanism in benign prostatic hyperplasia has not been established. ([clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04590534))

Other names

garcinia extract + chromiumgarcinia extract + chromium picolinate